Hi there

Who we are

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

More about us

Experience

A fine
balance

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Team

Greater perspectives create greater outcomes.

Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.

Companies

A dynamic
portfolio

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Companeis

The future looks bright.

Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.

Approach

A hand
in every stage

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

About

This is Canaan.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

Hi there

Who we are

>Astra

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

More about us

Experience

A fine
balance

>The RealReal

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Companies

A dynamic
portfolio

>IDEAYA Biosciences

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Approach

A hand
in every stage

>Berkshire Grey

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach
Highlight

Julie Grant to be Appointed to National Cancer Advisory Board

We are proud to share that President Biden has announced his intention to appoint Canaan’s Julie Grant, along with five others, to the National...
Highlight

Endpoints News: Grey Wolf Reels in $49M to Enter the Clinic for New Immunotherapy Target

When he finds the time to go fly fishing, Peter Joyce says gray wulffs, or mayfly mimics, are his good luck charm — he always catches a fish when...
Highlight

Endpoints News: Day One to file NDA for pediatric brain cancer drug by summer

Day One Biopharmaceuticals will ask regulators to approve its pediatric brain cancer drug tovorafenib before the second half of 2023, the biotech...
Highlight

BioCentury: Biotech investors bracing for Inflation Reduction Act’s impacts

VCs mull warnings from pharma CEOs that law will reduce incentives for small molecule drug development, precision medicine...